Latest Close
$12.55
News
ABCL
AbCellera Biologics Inc. News
This news view pulls recent coverage and headlines tied to ABCL.
1y Change
$7.01 (+126.85%)
Market Cap
$4.07B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
AbCellera Biologics (ABCL) Could Be 27% Undervalued As ABCL635 Data Draws Focus
Simply Wall St. • Oct 9, 2026
Read articleAbCellera to Present Phase 1/2 ABCL635 Data at Menopause Society Meeting
MT Newswires • Oct 9, 2026
Read articleWhat Could Go Wrong With Recursion Pharmaceuticals Stock?
Trefis • Oct 8, 2026
Read articleAbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
Business Wire • Oct 8, 2026
Read articleAbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
Business Wire • Oct 1, 2026
Read articleAI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
CNW Group • Oct 1, 2026
Read article